Prostate Cancer - Results from #2600

Germline ATM Mutations Detected by Somatic DNA Sequencing in Lethal Prostate Cancer. June 20, 2023

Association of TP53 Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men. June 20, 2023

Single-cell RNA sequencing reveals that HSD17B2 in cancer-associated fibroblasts promotes the development and progression of castration-resistant prostate cancer. June 20, 2023

Development and validation of nomogram to improve the specificity of multiparametric MRI for clinically significant prostate cancer. June 19, 2023

DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs. June 19, 2023

Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT? June 19, 2023

High-dose-rate brachytherapy as monotherapy versus as boost in unfavorable intermediate-risk localized prostate cancer: A matched-pair analysis. June 19, 2023

Oncological and perioperative outcomes of surgery with or without metastasis-directed therapy as part of a multimodal treatment in men with de-novo oligometastatic prostate cancer. June 19, 2023

Impact of prostate radiotherapy on survival outcomes in clinically node-positive prostate cancer: A multicentre retrospective analysis. June 19, 2023

The Risk of Catastrophic Healthcare Expenditures Among Prostate and Bladder Cancer Survivors in the United States. June 16, 2023

Inter-reader agreement of the prostate imaging quality (PI-QUAL) score for basic readers in prostate MRI: A multi-center study. June 16, 2023

Magnetic resonance imaging-targeted, systematic, or combined biopsy for detecting clinically significant prostate cancer. June 16, 2023

Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey. June 16, 2023

New tracers and combinations in radioligand therapy for prostate cancer. June 16, 2023

Data-driven strategies for increasing patient diversity in Bristol Myers Squibb-sponsored US oncology clinical trials. June 15, 2023

The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer. June 15, 2023

PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study. June 15, 2023

Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry. June 15, 2023

Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial. June 15, 2023

PSMA-Positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer June 14, 2023

Page 131 of 1439